Mr. Comer (for himself, Mr. Raskin, Mr. Duarte, Mr. Nadler, Mrs. González-Colón, and Ms. Plaskett) introduced the following bill; which was referred to the Committee on Oversight and Accountability, and in addition to the Committees on the Judiciary, and Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
Citations are generated automatically from bibliographic data as a convenience and may not be complete or accurate.
Chicago
U.S. Congress. House. Office of National Drug Control Policy Reauthorization Act of 2024. H.R. 9598. 118th
Cong., 2nd
sess., Introduced in House September 16, 2024. https://www.govinfo.gov/app/details/BILLS-118hr9598ih.
APA
Congress, House of Representatives (2024, September 16). Office of National Drug Control Policy Reauthorization Act of 2024 (H.R. 9598 (IH)). Retrieved from https://www.govinfo.gov/app/details/BILLS-118hr9598ih.
MLA
United States, Congress, House of Representatives. Office of National Drug Control Policy Reauthorization Act of 2024. U.S. Government Publishing Office, https://www.govinfo.gov/app/details/BILLS-118hr9598ih. 118th Congress, H.R. 9598, Introduced in House 16 Sep. 2024.
Bluebook
H.R.9598 - 118th Congress (2023-2024): Office of National Drug Control Policy Reauthorization Act of 2024, H.R.9598, 118th Cong. (2024), https://www.govinfo.gov/app/details/BILLS-118hr9598ih.
